Table 2.
Performance of Clinical & HD-CTM Models
| NSCLC vs. Benign | Stage I vs. Benign | ||||||
|---|---|---|---|---|---|---|---|
|
| |||||||
| Training n = 88 | Test n = 41 | All n = 129 | Training n = 71 | Test n = 34 | All n=105 | ||
| Clinical Variables Only* | AUC | 0.78 (0.68–0.89) | 0.75 (0.53–0.97) | 0.77 (0.68–0.87) | 0.80 (0.68–0.91) | 0.76 (0.54–0.97) | 0.79 (0.68–0.87) |
| Sens | 0.65 | 0.91 | 0.71 | 0.83 | 0.85 | 0.68 | |
| Spec | 0.88 | 0.63 | 0.80 | 0.71 | 0.63 | 0.84 | |
|
| |||||||
| Clinical & HD-CTM† | AUC | 0.88 (0.81–0.96) | 0.88 (0.66–0.99) | 0.88 (0.82–0.94) | 0.88 (0.79–0.97) | 0.88 (0.75–1.00) | 0.87 (0.82–0.94) |
| Sens | 0.79 | 0.72 | 0.82 | 0.82 | 0.78 | 0.83 | |
| Spec | 0.88 | 1.00 | 0.84 | 0.88 | 1.00 | 0.84 | |
AUC = Area under curve (C-statistic) with 95% confidence interval. Sens = Sensitivity; Spec = Specificity.
See Table 1 for variables and levels included in the clinical model.
See Supplemental Table 2 for significant variables in each model. Models that significantly add value to the clinical model are in bold.